Cencora Inc

Research Cencora Inc (COR) on Bullrun: valuation model: 10.5% undervalued, market cap USD 54.80B, P/E 21.6, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCOR
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Distribution
• CurrencyUSD
• Valuation signal10.5% undervalued
• Market capUSD 54.80B
• P/E21.6
• Dividend yield0.8%
• Financial periodFY2025
• RevenueUSD 321.33B
• Revenue growth9.3%
• Net incomeUSD 1.55B
• Free cash flowUSD 3.21B
• Gross margin3.6%

Valuation Snapshot

Bullrun's latest valuation model marks Cencora Inc as 10.5% undervalued; latest market cap is USD 54.80B; P/E is 21.6; dividend yield is 0.8%.

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers;

Frequently asked questions

Is Cencora Inc overvalued or undervalued?

Bullrun's valuation model currently marks Cencora Inc as 10.5% undervalued.

What is Cencora Inc's market cap?

Cencora Inc's market capitalization is USD 54.80B.

What is Cencora Inc's P/E ratio?

Cencora Inc's price-to-earnings (P/E) ratio is 21.6.

Does Cencora Inc pay a dividend?

Cencora Inc has a dividend yield of 0.8%.

What does Cencora Inc do?

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.